Compare VLO & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VLO | SYK |
|---|---|---|
| Founded | 1980 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.5B | 125.7B |
| IPO Year | 1997 | 1994 |
| Metric | VLO | SYK |
|---|---|---|
| Price | $369.13 | $309.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 30 |
| Target Price | ★ $421.32 | $339.37 |
| AVG Volume (30 Days) | ★ 2.9M | 2.7M |
| Earning Date | 10-22-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.30% | 1.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 40.29 | 7.19 |
| Revenue | ★ $122,687,000,000.00 | $25,116,000,000.00 |
| Revenue This Year | $41.12 | $6.75 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | ★ $9.18 | $43.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $159.90 | $267.00 |
| 52 Week High | $461.52 | $389.33 |
| Indicator | VLO | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 43.50 | 50.96 |
| Support Level | $364.96 | $309.51 |
| Resistance Level | $419.04 | $319.17 |
| Average True Range (ATR) | 15.63 | 10.33 |
| MACD | -1.07 | -1.43 |
| Stochastic Oscillator | 46.27 | 40.77 |
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.